木瓜直播

Phase IIb trial strongly favors safety of novel agent over DOAC, but stroke impact still unclear

News and commentary from the world of neurology and neuroscience

Also in TTHealthWatch: improving outcomes in large strokes

News and commentary from the world of neurology and neuroscience

Study results were neutral for periprocedural intra-arterial urokinase, tenecteplase

Device was recently approved for drug-refractory paroxysmal atrial fibrillation

Lower risk of all-cause and cardiovascular mortality observed only among morning drinkers

News and commentary from the world of neurology and neuroscience

Biomarker of wine consumption believed to reduce misclassification and bias in study

Tenecteplase is cheaper and easier to administer, says researcher

Medical experts discuss possible causes, treatments

Health news and commentary gathered by 木瓜直播 staff

Observational study suggests one antihypertensive class might be preventive

Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system